Dr. Neilan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Longwood Ave
Boston, MA 02115Phone+1 617-355-6394
Summary
- Dr. Edward Neilan is a medical geneticist in Boston, MA. Dr. Neilan is the Chief Medical and Scientific Officer at the National Organization for Rare Disorders (NORD), and he is affiliated with Boston Children's Hospital. He received his medical degree from Stanford University School of Medicine and has been in practice 19 years. He specializes in clinical biochemical genetics and clinical genetics.
Education & Training
- Boston Children’s Hospital/Harvard Medical SchoolResidency, Medical Genetics and Genomics, 2001 - 2004
- Boston Children’s Hospital/Harvard Medical SchoolFellowship, Medical Genetics and Genomics, 2004
- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1998 - 2001
- Stanford University School of MedicineClass of 1998
Certifications & Licensure
- MA State Medical License 2001 - 2026
- American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
- American Board of Medical Genetics and Genomics Clinical Genetics
- American Board of Pediatrics Pediatrics
Clinical Trials
- Pharmacokinetics and Safety Study of Single and Multiple Oral Doses Prodarsan™ in Patients With Cockayne Syndrome Start of enrollment: 2010 Jun 01
Publications & Presentations
PubMed
- 121 citationsCopy number variation plays an important role in clinical epilepsyHeather E. Olson, Yiping Shen, Jennifer Avallone, Beth Rosen Sheidley, Rebecca Pinsky
Annals of Neurology. 2014-06-01 - 76 citationsDysregulation of gene expression as a cause of Cockayne syndrome neurological diseaseYuming Wang, Probir Chakravarty, Michael Ranes, Gavin Kelly, Philip J. Brooks
Proceedings of the National Academy of Sciences of the United States of America. 2014-10-07 - 139 citationsMutations in UVSSA cause UV-sensitive syndrome and destabilize ERCC6 in transcription-coupled DNA repairXue Zhang, Katsuyoshi Horibata, Masafumi Saijo, Chie Ishigami, Akiko Ukai
Nature Genetics. 2012-05-01
Press Mentions
- National Organization for Rare Disorders (NORD) Launches the Living Rare Study – First to Measure Full Scope of Rare Disease ChallengesOctober 21st, 2024
- National Organization for Rare Disorders (NORD) Welcomes Edward Neilan, MD, PhD, as Chief Medical and Scientific OfficerMay 27th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: